HGHoward P. Gutgesell

Howard P. Gutgesell

*This is an algorithmically generated author record based on publicly available information.

Howard P. Gutgesell has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Kimberly E. McHugh

    Department of Pediatrics, Medical University of South Carolina, Charleston, South Carolina

    3 shared publications
  • Diane G. Hillman

    Department of Public Health Sciences, Division of Clinical Informatics, University of Virginia Health System, Charlottesville, VA, USA

    2 shared publications
  • D Scott Lim

    1 shared publication
  • David M Barton

    1 shared publication
  • Dha Diane G. Hillman

    Public Health Sciences, University of Virginia Health System, Charlottesville, Virginia; and

    1 shared publication
  • G. Paul Matherne

    Department of Pediatrics, Division of Cardiology, University of Virginia Health System, Charlottesville, VA, USA

    1 shared publication

Latest Publications

  • Inpatient Costs and Charges for Surgical Treatment of Hypoplastic Left Heart Syndrome

    by Peter N. Dean, Dha Diane G. Hillman, Kimberly E. McHugh, Howard P. Gutgesell

    OBJECTIVE: Hypoplastic left heart syndrome (HLHS) is one of the most serious congenital cardiac anomalies. Typically, it is managed with a series of 3 palliative operations or cardiac transplantation. Our goal was to quantify the inpatient resource burden of HLHS across multiple academic medical centers.METHODS: The University HealthSystem Consortium is an alliance of 101 academic medical centers and 178 affiliated hospitals that share diagnostic, procedural, and financial data on all discharges. We examined inpatient resource use by patients with HLHS who underwent a staged palliative procedure or cardiac transplantation between 1998 and 2007.RESULTS: Among 1941 neonates, stage 1 palliation (Norwood or Sano procedure) had a median length of stay (LOS) of 25 days and charges of $214 680. Stage 2 and stage 3 palliation (Glenn and Fontan procedures, respectively) had median LOS and charges of 8 days and $82 174 and 11 days and $79 549, respectively. Primary neonatal transplantation had an LOS of 87 days and charges of $582 920, and rescue transplantation required 36 days and $411 121. The median inpatient wait time for primary and rescue transplants was 42 and 6 days, respectively. Between 1998 and 2007, the LOS for stage 1 palliation increased from 16 to 28 days and inflation-adjusted charges increased from $122 309 to $280 909, largely because of increasing survival rates (57% in 1998 and 83% in 2007).CONCLUSIONS: Patients with HLHS demand considerable inpatient resources, whether treated with the Norwood-Glenn-Fontan procedure pathway or cardiac transplantation. Improved survival rates have led to increased hospital stays and costs.


  • Use of an Administrative Database to Determine Clinical Management and Outcomes in Congenital Heart Disease

    by Howard P. Gutgesell, Diane G. Hillman, Kimberly E. McHugh, Peter Dean, G. Paul Matherne

    We review our 16-year experience using the large, multi-institutional database of the University HealthSystem Consortium to study management and outcomes in congenital heart surgery for hypoplastic left heart syndrome, transposition of the great arteries, and neonatal coarctation. The advantages, limitations, and use of administrative databases by others to study congenital heart surgery are reviewed.


  • Screening for Cardiovascular Disease in the Young

    by Howard P. Gutgesell

    America's youth have been screened for cardiovascular disorders for nearly a century. Initial efforts to detect rheumatic heart disease in schoolchildren have gradually shifted to the detection of congenital heart disease in the fetus and newborn, and to the prevention of sudden cardiac death in older children, especially athletes. Proposed screening programs need to consider sensitivity and specificity, cost, resource availability, and the potential for adverse effects of the screening process.


  • Three-stage Palliation of Hypoplastic Left Heart Syndrome in the University HealthSystem Consortium

    by Kimberly E. McHugh, Diane G. Hillman, Matthew J. Gurka, Howard P. Gutgesell

    The objective of this study was to describe current management and short-term outcomes for patients with hypoplastic left heart syndrome representative of nationwide experience. Additionally, this study identifies risk factors associated with mortality in patients undergoing staged surgical palliation. The University HealthSystem Consortium database was queried to identify all hospital admissions between 1998 and 2007 with a diagnosis of hypoplastic left heart syndrome. Procedure codes were used to determine surgical management, and outcomes were ascertained by discharge status (discharged, transferred, or expired). Discharge data were present from 118 hospitals in the United States. First-stage surgical palliation was performed in 1949 neonates with 30% mortality. Mortality decreased from 43% in 1998 to 18% in 2007. Large institutional case volume and later era of surgery were associated with improved operative mortality in first-stage palliation. Primary cardiac transplantation was performed in 28 neonates, and rescue transplantation in 11, with 36% mortality. Second-stage palliation was performed in 1244 patients with 5.2% mortality, and third-stage palliation was performed in 1084 patients with 4.1% mortality. An additional 62 patients over 1 month of age at time of admission received cardiac transplantation with 15% mortality. First-stage palliative mortality for hypoplastic left heart syndrome fell dramatically over the past decade, while that for second- and third-stage procedures remained stable. The cumulative operative mortality for three-staged repair of hypoplastic left heart syndrome was 39% over the decade, but fell to 24% for procedures in 2007.


  • Hybrid palliation in hypoplastic left heart syndrome

    by Howard P Gutgesell, D Scott Lim

    Despite progressive improvement in surgical results, hypoplastic left heart syndrome remains one of the congenital heart abnormalities with the greatest morbidity and mortality. Hybrid approaches to management, combining surgical and interventional catheterization procedures, have been introduced to minimize exposure to cardiopulmonary bypass, and improve outcomes for these high-risk infants. First-stage palliation of hypoplastic left heart syndrome has been performed as a hybrid procedure combining surgical pulmonary artery banding with catheterization stenting of the ductus arteriosus and balloon atrial septostomy, especially in high-risk patients. Additionally, several centers have performed second-stage palliation - bidirectional Glenn or hemi-Fontan procedures - in a manner that allows the subsequent 'Fontan' procedure to be completed in the catheterization laboratory with a covered stent. These innovative procedures offer the potential of an alternative management strategy for hypoplastic left heart syndrome. They have been applied to a very limited number of patients and long-term results are not available. Their role in management of hypoplastic left heart syndrome remains to be defined, especially as results of conventional surgical management continue to improve.